Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search span> per specialist: Markus Raderer, Prof
Woman and Man Max 99 years
Markus Raderer, Prof
Update Il y a 5 ans
Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients
The purpose of this study is to evaluate Thalidomide for treatment of disseminated MALT Lymphoma or at relapse following helicobacter pylori (HP) - eradication or chemotherapy or radiation...
Country
Austria
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Markus Raderer, Prof. Dr
Update Il y a 5 ans
Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
The purpose of this trial is to evaluate whether a Rituximab plus 2 CdA combination therapy is effective and safe in the treatment of patients with advanced or relapsed lymphoma of the muc...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Markus Raderer, Prof
Update Il y a 5 ans
Velcade in MALT Lymphoma Patients
Bortezomib for treatment of disseminated MALT lymphoma or at relapse following HP -eradication,or chemotherapy or radiation.
Country
None
organs
None
Specialty
None
Closed trial
More information